BlackRock trims ChemoMetec share voting rights below 15%
Alpha Vantage · Yahoo Finance UK · · AI-summarised by FinFlash
BlackRock cut its voting rights attached to ChemoMetec A/S shares to 14.97% on October 15, 2026, dropping below the 15% threshold. Its voting rights held through financial instruments rose to 0.11%, leaving the combined position at 15.08%. The shift is a technical reclassification rather than an exit, so the aggregate stake is essentially unchanged for investors tracking ownership.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.